Alterity Therapeutics Limited | PRAN - Cash And Equivalent


Alterity Therapeutics Limited reported AUD15.77M in Cash and Equivalent for its fiscal semester ending in June of 2023.





Cash And Equivalent Change Date
Alterity Therapeutics Limited AUD 15.77M 9.56M Jun/2023
Arca Biopharma USD 49.52M 2.58M Mar/2026
aTyr Pharma USD 10.01M 735K Mar/2026
Bio Path 13.65M 3.37M Sep/2022
Brainstorm Cell Therapeutics USD 15K 14K Mar/2026
Capricor Therapeutics USD 105.42M 182.42M Mar/2026
Cara Therapeutics USD 20.73M 684K Dec/2025
CSL USD 2.16B 633M Jun/2025
Esperion Therapeutics USD 156.16M 11.69M Mar/2026
Immunic USD 186.63M 171.15M Mar/2026
Infinity Pharmaceuticals USD 17.75M 7.99M Jun/2023
Insmed USD 582.19M 71.74M Mar/2026
Minerva Neurosciences USD 82.3M 70.02M Dec/2025
Sangamo BioSciences USD 38.34M 13.16M Jun/2025
TherapeuticsMD 523K 89K Jun/2024